Literature DB >> 2029351

The adverse effects of angiographic radiocontrast media.

M Westhoff-Bleck1, J S Bleck, S Jost.   

Abstract

Radiographic procedures which require the intravascular administration of water-soluble radiocontrast media are performed with increasing frequency. Each examination carries risks that are related either to the technique itself or to the opaque medium chosen. The pathogenesis of radiocontrast media-related adverse effects cannot be explained by a unique theory. The major factors implicated are direct chemotoxic effects and the physicochemical properties of contrast media, the latter being the basis for development of new contrast agents. With nonionic opaque media cardiovascular adverse effects, heat sensation and local pain are observed less frequently. However, it remains unclear whether the incidence of organ dysfunction or anaphylactic reactions with nonionic contrast media currently used can be reduced. This review compares ionic and nonionic contrast media, and current thoughts on the pathophysiology and treatment of adverse reactions are presented.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029351     DOI: 10.2165/00002018-199106010-00003

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  60 in total

Review 1.  Use of conventional and newer radiographic contrast agents in cardiac angiography.

Authors:  P C Hanley; D R Holmes; P R Julsrud; H C Smith
Journal:  Prog Cardiovasc Dis       Date:  1986 May-Jun       Impact factor: 8.194

2.  In vitro models for testing the metabolic effects of myelographic contrast media.

Authors:  T W Morris; S E Ekholm; J H Simon; G V Marinetti; P P Harnish; L Isaac; D Fonte; P Leakey
Journal:  Invest Radiol       Date:  1988-09       Impact factor: 6.016

3.  Mechanism of the bradycardia during coronary angiography.

Authors:  R J Frink; B Merrick; H M Lowe
Journal:  Am J Cardiol       Date:  1975-01       Impact factor: 2.778

Review 4.  Kinetics of water-soluble contrast media in the central nervous system.

Authors:  M R Sage
Journal:  AJR Am J Roentgenol       Date:  1983-10       Impact factor: 3.959

5.  The current status of reactions to intravenous contrast media.

Authors:  G Ansell; M C Tweedie; C R West; P Evans; L Couch
Journal:  Invest Radiol       Date:  1980 Nov-Dec       Impact factor: 6.016

6.  Contrast media: quantitative criteria for designing compounds with low toxicity.

Authors:  H Levitan; S I Rapoport
Journal:  Acta Radiol Diagn (Stockh)       Date:  1976-01

7.  Combined actions of verapamil and contrast media on atrioventricular conduction. Influence of osmolality of the media.

Authors:  W W Peck; R A Slutsky; G B Mancini; C B Higgins
Journal:  Invest Radiol       Date:  1984 May-Jun       Impact factor: 6.016

8.  The influence of contrast media additives upon ventricular fibrillation thresholds during coronary angiography in ischemic and normal canine hearts.

Authors:  G L Wolf; R F Le Veen; C Mulry; K Kilzer
Journal:  Cardiovasc Intervent Radiol       Date:  1981       Impact factor: 2.740

Review 9.  Results of randomized controlled trials of low-versus high-osmolality contrast media.

Authors:  M L Kinnison; N R Powe; E P Steinberg
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

10.  Systemic hypocalcemia after clinical injections of radiographic contrast media: amelioration by omission of calcium chelating agents.

Authors:  L E Mallette; L S Gomez
Journal:  Radiology       Date:  1983-06       Impact factor: 11.105

View more
  2 in total

Review 1.  An overview of chronic urticaria.

Authors:  Vincent S Beltrani
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

Review 2.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.